» Articles » PMID: 15342377

Inverse Correlation Between Cyclin A1 Hypermethylation and P53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing

Overview
Journal Cancer Res
Specialty Oncology
Date 2004 Sep 3
PMID 15342377
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant promoter hypermethylation of tumor suppressor genes is proposed to be a common feature of primary cancer cells. We recently developed a pharmacological unmasking microarray approach to screen unknown tumor suppressor gene candidates epigenetically silenced in human cancers. In this study, we applied this method to identify such genes in head and neck squamous cell carcinoma (HNSCC). We identified 12 novel methylated genes in HNSCC cell lines, including PGP9.5, cyclin A1, G0S2, bone-morphogenetic protein 2A, MT1G, and neuromedin U, which showed frequent promoter hypermethylation in primary HNSCC (60%, 45%, 35%, 25%, 25%, and 20%, respectively). Moreover, we discovered that cyclin A1 methylation was inversely related to p53 mutational status in primary tumors (P = 0.015), and forced expression of cyclin A1 resulted in robust induction of wild-type p53 in HNSCC cell lines. Pharmacological unmasking followed by microarray analysis is a powerful tool to identify key methylated tumor suppressor genes and relevant pathways.

Citing Articles

Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.

Mesgari H, Esmaelian S, Nasiri K, Ghasemzadeh S, Doroudgar P, Payandeh Z Cancers (Basel). 2023; 15(23).

PMID: 38067304 PMC: 10705512. DOI: 10.3390/cancers15235600.


Pivotal Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) in Uterine Leiomyoma.

Suzuki T, Dai Y, Ono M, Kojima J, Sasaki T, Fujiwara H Biomolecules. 2023; 13(2).

PMID: 36830563 PMC: 9953523. DOI: 10.3390/biom13020193.


Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.

Gonzalez M, Olivas I, Bencomo-Alvarez A, Rubio A, Barreto-Vargas C, Lopez J Clin Transl Med. 2022; 12(12):e1146.

PMID: 36536477 PMC: 9763536. DOI: 10.1002/ctm2.1146.


Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma.

Xu P, Zhao R, Zhang C, Zhang Q, Wang Y, Zhu J Cell Death Discov. 2021; 7(1):386.

PMID: 34897285 PMC: 8665927. DOI: 10.1038/s41420-021-00777-6.


Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma.

Yang D, Zhang X, Li Z, Xu F, Tang C, Chen H PeerJ. 2021; 9:e11512.

PMID: 34141479 PMC: 8176915. DOI: 10.7717/peerj.11512.